
Pennsylvania has lifted its six-month moratorium on new hospice enrollments in the state’s Medical Assistance program, effective November 15, 2026. But a separate nationwide Medicare enrollment freeze remains in place after federal regulators extended it for another six months. For a would-be hospice operator, the change in Harrisburg does not necessarily mean that enrollment in both programs is now possible.
The Pennsylvania Department of Human Services announced the state decision in a notice published November 14. It said the state was ending its pause because the federal Medicare moratorium was due to expire on November 15. By the time the state notice appeared, federal policy had changed: the Centers for Medicare & Medicaid Services (CMS) had announced an extension on November 12.
The distinction matters because Pennsylvania requires a hospice to be Medicare-certified before it can enroll in Medical Assistance, the state’s Medicaid program. Removing Pennsylvania’s own temporary bar does not remove the federal obstacle facing an applicant that still needs initial Medicare enrollment.
Pennsylvania ends a state restriction imposed in May
The state’s moratorium began May 15, two days after CMS put its first nationwide Medicare hospice restriction into effect. Pennsylvania’s June Medical Assistance bulletin said the move covered hospices seeking to enroll in its Medicaid program and reflected concerns about fraud, waste and abuse. It also specified that already enrolled hospices could continue providing services to Medicaid beneficiaries.
Pennsylvania’s November notice ends that six-month state restriction rather than establishing a new licensing or certification standard. The ordinary requirements for hospice participation still apply. Under state rules cited in both the original and the latest notices, a provider must be Medicare-certified and meet federal hospice conditions of participation to qualify for enrollment in the Medical Assistance program.
That leaves an important difference between a hospice that already has Medicare certification but has not yet joined Pennsylvania Medicaid and a newly formed operator that cannot currently enter Medicare. The former may have a route to seek state enrollment, subject to the usual review and other applicable requirements. The latter cannot treat the state notice as permission to bypass federal certification and enrollment requirements.
The Department of Human Services said it did not anticipate a fiscal impact from the expiration of its moratorium. That is the state’s assessment of the administrative policy change, not a forecast of how many providers will enroll or how hospice spending might change over time. The notice gives no estimate for new applications or approvals.
CMS keeps its national ban on initial Medicare enrollment
CMS took a different course at the federal level. In its November 12 announcement, the agency said the nationwide restrictions on new Medicare enrollments for hospices and home health agencies would continue for six more months. The hospice extension applies to initial enrollment applications, including certain changes in majority ownership that require the affected provider to enroll anew under federal rules.
Applications subject to the moratorium are denied while it remains in effect. The restriction applies across the country, including Pennsylvania; changing the state in which a new hospice seeks to enter Medicare does not avoid the federal rule. CMS can extend a moratorium again in six-month increments if it determines that the relevant risks remain.
The extension is narrower than the original federal pause in one respect. An existing Medicare-enrolled hospice may add a practice location to its existing enrollment in the same state, subject to the applicable enrollment and certification procedures. The first phase of the moratorium had also restricted new practice locations. CMS said it is more concerned, at present, about unfamiliar new operators than about an established provider expanding under an existing enrollment.
That exception should not be confused with permission to enroll a separate new hospice. Nor does every ownership change automatically trigger a fresh Medicare enrollment: the federal moratorium reaches nonexempt changes in majority ownership for which the rules require the provider to start over. Whether a particular restructuring qualifies depends on the federal enrollment requirements, not merely on the Pennsylvania announcement.
Hospices already enrolled in Medicare are not required to stop operating because of the extension. CMS said they can continue delivering services and billing for covered care. The agency’s action concerns entry into the program, not a general suspension of the Medicare hospice benefit for existing patients.
CMS cited continued risks of fraudulent hospice billing and inappropriate patient enrollment in explaining its decision. Its federal notice describes schemes involving beneficiaries enrolled without their knowledge or certified for hospice services they did not medically need. These are examples used by regulators to explain a nationwide safeguard; they are not findings about every hospice or allegations against Pennsylvania providers as a group.
The agency also pointed to an earlier enhanced-oversight effort in Arizona, California, Nevada and Texas. By June 2025, approximately 670 hospices were subject to medical review under that effort and 122 had been revoked from Medicare, according to CMS. Those figures describe a targeted multistate review, not a Pennsylvania enrollment count, and they do not establish that the same problems exist at the same rate in every state.
Separate federal and state decisions leave a narrow opening
The federal and state announcements can coexist because they govern different enrollment decisions. In its original May hospice notice, CMS specifically left each state to decide whether a comparable Medicaid or Children’s Health Insurance Program moratorium was appropriate locally. The new federal extension repeats that position and says the decision on state-level moratoria remains with the state or territory.
CMS identified Pennsylvania, Louisiana, Nevada, Ohio and Rhode Island as states that had adopted hospice moratoria in response to the initial federal action. Its extension was not intended to dictate whether those state restrictions should continue. Pennsylvania can therefore end its own Medicaid-specific pause even as CMS continues rejecting new Medicare hospice applications covered by the federal moratorium.
The overlap still has practical consequences. A provider with an established Medicare enrollment may be in a different position from a startup that has not completed federal enrollment. State-level relief can matter to the first group, but cannot by itself deliver the Medicare status Pennsylvania requires. Operators planning to open a hospice, acquire one or add a location must distinguish the federal rules for initial enrollment from the rules for existing providers and the state’s separate Medicaid process.
CMS said its monitoring had found no evidence that the first nationwide hospice moratorium materially reduced Medicare patients’ access to hospice services, and that states had not reported related Medicaid or CHIP access problems. That is the federal agency’s assessment, not a guarantee that no community has faced a local shortage. Both agencies have left existing providers’ ability to care for enrolled patients intact.
Pennsylvania’s notice invites written comments within 30 days for consideration in any future decision about a hospice enrollment moratorium. At the federal level, the newly extended Medicare restriction remains subject to CMS review before the next six-month period ends. Until CMS lifts or changes that restriction, Pennsylvania’s state action should not be read as a general reopening of new Medicare hospice enrollment.
Latest News
View all news- CVS Health Study Finds GLP-1 Medical Savings Do Not Fully Offset Drug Costs at Current Prices
- Bitcoin Falls Near $62,000 as Crypto Selloff Deepens Following U.S. ETF Outflows
- Singapore Central Bank Details SME Financing and Digital-Money Agenda for FinTech Festival
- Novo Nordisk Releases New CagriSema Analysis Showing 25.4% Weight Loss Among Early Responders
- Jollibee Franchise Agreements Target 35 Australian Stores and A$60 Million in Investment